Composition
| Component | Per vial | Research focus |
|---|---|---|
| Cartalax (AED) | 10 mg | Gene expression in chondrocytes and fibroblasts |
| BPC-157 | 5 mg | Blood vessel formation, tendon and tissue models |
| TB-500 | 5 mg | Actin binding, cell migration |
The components
Cartalax is a tripeptide of alanine, glutamic acid and aspartic acid from the short bioregulators of the St Petersburg Institute of Bioregulation and Gerontology; work describes effects on differentiation markers in cartilage and connective-tissue cells, mostly from one group. BPC-157 and TB-500 are the best-known regeneration peptides. There are no studies of the combination.
Status
No component is approved. Each is detected separately by the laboratory. Research use only; cartalax is also available on its own.







